1,033
Participants
Start Date
September 30, 2001
Primary Completion Date
November 30, 2003
Study Completion Date
November 30, 2003
Rimonabant (SR141716)
Altoona Center for Clinical Research, Duncansville
Clinical Research Division, Newtown
Johns Hopkins Women's Research Core, Lutherville
Clinical Research Center of Northern Virginia, Falls Church
Hunter Holmes McGuire Medical Center Research Service (151), Richmond
Medical University of South Carolina, Division of Clinical Pharmacology, Charleston
Clinical Research of South Florida, Coral Gables
Radiant Research, Stuart
Nashville Medical Research Institute, Nashville
Bluegrass Clinical Research, Inc., Louisville
nTouch Research, South Bend
Twin Cities Clinical Research, Arden Hills
Radiant Research, Edina
Clinical Research Services, Bismarck
nTouch Research, Peoria
Women's Clinic of Lincoln, PC, Lincoln
Radiant Research, Salt Lake City
Clinic of Physicians and Surgeons, LTD, Mesa
Arizona Clinical Research Center, Inc., Tucson
New Mexico Clinical Research & Osteoporosis Center, Inc., Albuquerque
Los Angeles Clinical Trials, Los Angeles
Irvine Center for Clinical Research (ICCR), Irvine
Apexute, Santa Ana
Vancouver Medical Weight Loss Clinic, Vancouver
Baystate Medical Center, Springfield
University of Cincinnati College of Medicine, Cincinnati
Clinical Research Center of Reading, LLC, West Reading
Addiction & Psychiatric Medicine Research, Morgantown
Sanofi-aventis Administrative Office, Macquarie Park
Sanofi-aventis Administrative Office, Laval
Sanofi-aventis Administrative Office, Helsinki
Sanofi-aventis Administrative Office, Milan
Sanofi-aventis Administrative Office, Barcelona
Sanofi-aventis Administrative Office, Bromma
Sanofi-aventis Administrative Office, Geneva
Lead Sponsor
Sanofi
INDUSTRY